Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells

Abstract Cannabinoids have been shown to induce anti‐tumor activity in a variety of carcinoma cells such as breast, prostate, and brain. The aim of the present study is to investigate the anti‐tumor activity of cannabinoids, CBD (cannbidiol), and CBG (cannabigerol) in ovarian carcinoma cells sensiti...

Full description

Bibliographic Details
Main Authors: Kartheek Sooda, Simon J. Allison, Farideh A. Javid
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.1152
_version_ 1797389547802198016
author Kartheek Sooda
Simon J. Allison
Farideh A. Javid
author_facet Kartheek Sooda
Simon J. Allison
Farideh A. Javid
author_sort Kartheek Sooda
collection DOAJ
description Abstract Cannabinoids have been shown to induce anti‐tumor activity in a variety of carcinoma cells such as breast, prostate, and brain. The aim of the present study is to investigate the anti‐tumor activity of cannabinoids, CBD (cannbidiol), and CBG (cannabigerol) in ovarian carcinoma cells sensitive and resistant to chemotherapeutic drugs. Sensitive A2780 cells and resistant A2780/CP70 carcinoma cells and non‐carcinoma cells were exposed to varying concentrations of CBD, CBG, carboplatin or CB1 and CB2 receptor antagonists, AM251 and AM630, respectively, alone or in combination, at different exposure times and cytotoxicity was measured by MTT assay. The mechanism of action of CBD and CB in inducing cytotoxicity was investigated involving a variety of apoptotic and cell cycle assays. Treatment with CBD and CBG selectively, dose and time dependently reduced cell viability and induced apoptosis. The effect of CBD was stronger than CBG in all cell lines tested. Both CBD and CBG induced stronger cytotoxicity than afforded by carboplatin in resistant cells. The cytotoxicity induced by CBD was not CB1 or CB2 receptor dependent in both carcinoma cells, however, CBG‐induced cytotoxicity may involve CB1 receptor activity in cisplatin‐resistant carcinoma cells. A synergistic effect was observed when cannabinoids at sublethal doses were combined with carboplatin in both carcinoma cells. The apoptotic event may involve loss of mitochondrial membrane potential, Annexin V, caspase 3/7, ROS activities, and cell cycle arrest. Further studies are required to investigate whether these results are translatable in the clinic. Combination therapies with conventional cancer treatments using cannabinoids are suggested.
first_indexed 2024-03-08T22:58:27Z
format Article
id doaj.art-63c83b610b27480e85f83f8e4e45f3e4
institution Directory Open Access Journal
issn 2052-1707
language English
last_indexed 2024-03-08T22:58:27Z
publishDate 2023-12-01
publisher Wiley
record_format Article
series Pharmacology Research & Perspectives
spelling doaj.art-63c83b610b27480e85f83f8e4e45f3e42023-12-16T03:52:32ZengWileyPharmacology Research & Perspectives2052-17072023-12-01116n/an/a10.1002/prp2.1152Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cellsKartheek Sooda0Simon J. Allison1Farideh A. Javid2Department of Pharmacy, School of Applied Sciences University of Huddersfield Huddersfield UKDepartment of Biological & Geographical Sciences, School of Applied Sciences University of Huddersfield Huddersfield UKDepartment of Pharmacy, School of Applied Sciences University of Huddersfield Huddersfield UKAbstract Cannabinoids have been shown to induce anti‐tumor activity in a variety of carcinoma cells such as breast, prostate, and brain. The aim of the present study is to investigate the anti‐tumor activity of cannabinoids, CBD (cannbidiol), and CBG (cannabigerol) in ovarian carcinoma cells sensitive and resistant to chemotherapeutic drugs. Sensitive A2780 cells and resistant A2780/CP70 carcinoma cells and non‐carcinoma cells were exposed to varying concentrations of CBD, CBG, carboplatin or CB1 and CB2 receptor antagonists, AM251 and AM630, respectively, alone or in combination, at different exposure times and cytotoxicity was measured by MTT assay. The mechanism of action of CBD and CB in inducing cytotoxicity was investigated involving a variety of apoptotic and cell cycle assays. Treatment with CBD and CBG selectively, dose and time dependently reduced cell viability and induced apoptosis. The effect of CBD was stronger than CBG in all cell lines tested. Both CBD and CBG induced stronger cytotoxicity than afforded by carboplatin in resistant cells. The cytotoxicity induced by CBD was not CB1 or CB2 receptor dependent in both carcinoma cells, however, CBG‐induced cytotoxicity may involve CB1 receptor activity in cisplatin‐resistant carcinoma cells. A synergistic effect was observed when cannabinoids at sublethal doses were combined with carboplatin in both carcinoma cells. The apoptotic event may involve loss of mitochondrial membrane potential, Annexin V, caspase 3/7, ROS activities, and cell cycle arrest. Further studies are required to investigate whether these results are translatable in the clinic. Combination therapies with conventional cancer treatments using cannabinoids are suggested.https://doi.org/10.1002/prp2.1152apoptosiscannabinoidsCBDCBGovarian cancer
spellingShingle Kartheek Sooda
Simon J. Allison
Farideh A. Javid
Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells
Pharmacology Research & Perspectives
apoptosis
cannabinoids
CBD
CBG
ovarian cancer
title Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells
title_full Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells
title_fullStr Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells
title_full_unstemmed Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells
title_short Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells
title_sort investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells
topic apoptosis
cannabinoids
CBD
CBG
ovarian cancer
url https://doi.org/10.1002/prp2.1152
work_keys_str_mv AT kartheeksooda investigationofthecytotoxicityinducedbycannabinoidsonhumanovariancarcinomacells
AT simonjallison investigationofthecytotoxicityinducedbycannabinoidsonhumanovariancarcinomacells
AT faridehajavid investigationofthecytotoxicityinducedbycannabinoidsonhumanovariancarcinomacells